Objective: To determine whether the net release of beta-endorphin duri
ng exercise, similar to that of norepinephrine, is related to function
al disability in patients with congestive heart failure, Background: P
lasma beta-endorphin and norepinephrine levels are elevated at rest in
patients with heart failure, reflecting a functional disability. The
net release of beta-endorphin during exercise in patients with heart f
ailure is unknown, Methods: We measured plasma beta-endorphin and nore
pinephrine levels (respectively: radioimmune and radioenzymatic assay)
at rest and during graded exercise testing in 28 patients with conges
tive heart failure (Weber's class A, 10; B, 9; and C, 9) and in 9 norm
al subjects, Results: At rest, plasma beta-endorphin levels were highe
r in patients in classes B and C than in normal subjects (p<0.05 and <
0.01, respectively). At peak exercise, patients in different functiona
l classes and normal subjects reached similar beta-endorphin levels. H
owever, the net release of beta-endorphin during exercise was lower in
patients in classes B and C than in those in class A and normal subje
cts (p<0.01 for both), At rest, plasma norepinephrine levels were sign
ificantly higher in patients than in normal subjects (p<0.01). At peak
exercise, norepinephrine levels were significantly lower in class C p
atients than in normal subjects (p<0.05), and tended to be lower in pa
tients in classes A and B (p=NS); The net release of norepinephrine du
ring exercise was lower in patients than in normal subjects (p<0.01).
In patients, releases of both beta-endorphin and norepinephrine during
exercise were related to peak oxygen consumption and duration of exer
cise, but not to resting left ventricular ejection fraction, Conclusio
ns: In patients with congestive heart failure, the net release of plas
ma beta-endorphin during exercise is decreased, like norepinephrine, a
nd reflects a functional disability.